MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Synfini, Inc., provider of the industry’s most advanced Agile AI Foundry for drug discovery, today announced the launch of Fast Pass I, an open, rapid cloud workflow system which provides qualified applicants complimentary access to SynRouteTM, Synfini’s retrosynthetic exploration and synthesis planning system, and SynDBTM, Synfini’s…
Washington, D.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- A video presentation featuring economic analyst and former government advisor Jim Rickards is now available for public viewing, examining how large portions of America’s mineral and resource base have remained undeveloped — and why recent legal and policy changes may begin to alter that reality.
MONACO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Knowledge-sharing, innovation and collective commitment. The Yacht Club de Monaco kicks off a new season following its ‘Monaco, Capital of Advanced Yachting’ approach. In 2026, as part of its public service remit to enhance the Principality’s appeal, the Club confirms its role as a focal point of activity…
Lewes, Delaware, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Global Electric Powertrain Market Size is projected to grow at a CAGR of 13.20% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 85.71 Billion in 2024 and is expected to reach…
Largo, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting any skincare treatment. If you purchase through links in this article, a commission may be earned at no additional cost to you.
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, Inc. (“Tesaro”) regarding their Collaboration and Exclusive License…
